Healthy adult volunteers aged 18-50 years were randomly assigned ( 5:1 ) to receive three injections of vaccine or placebo at weeks 0 , 4 , and 8 , with vaccine allocations divided equally between three active vaccine groups : EBO vaccine only , MAR vaccine only , and both vaccines .